Clinical Trial

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study investigates the effects of brain radiotherapy on cognitive function by evaluating plasma biomarkers and apolipoprotein E (APOE) genotype in patients with primary or metastatic brain tumors. Standard brain radiotherapy is known to impact cognitive outcomes, yet the underlying biological mechanisms remain unclear.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-06.
Trial Details
NCT Number NCT07226466
Lead Sponsor University of California, San Francisco
Conditions Brain Tumor Adult, Brain Metastases From Solid Tumors, Brain Tumor, Primary, Brain Tumor
Enrollment 40 participants
Start Date 2026-07-01
Primary Completion 2028-10-31 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-22